DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cardiac Biomarkers - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Cardiac Biomarkers in US$ Thousand by the following Testing Locations: Laboratory Testing, and Point of Care Testing. The Global, US and European markets are further analyzed by the following Test Types: Cardiac Troponin, BNP and NT-proBNP, and Others.
Company profiles are primarily based on public domain information including company URLs. The report profiles 44 companies including many key and niche players such as -
- Abbott Diagnostics, Inc.
- Alere, Inc.
- Beckman Coulter, Inc.
- BG Medicine, Inc.
-
biomérieux SA
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. MARKET GROWTH DRIVERS, TRENDS & ISSUES
3. PRODUCT OVERVIEW
4. PRODUCT INTRODUCTIONS
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT PLAYERS
-
Abbott Diagnostics, Inc.
-
Alere, Inc.
-
Beckman Coulter, Inc.
-
BG Medicine, Inc.
-
biomérieux SA
-
Boditech Med Inc.
-
Labsystems Diagnostics OY
-
LifeSign LLC
-
LSI Medience Corporation
-
Ortho-Clinical Diagnostics, Inc.
-
Randox Laboratories Ltd.
-
Response Biomedical Corp.
-
Roche Diagnostics Corp.
-
Siemens Healthcare Diagnostics, Inc.
-
Singulex, Inc.
7. GLOBAL MARKET PERSPECTIVE
For more information visit http://www.researchandmarkets.com/research/zm69qh/cardiac
